142 related articles for article (PubMed ID: 11449303)
41. [Clinicogenetic study of MEN1: recent physiopathological data and clinical applications. Study Group of Multiple Endocrine Neoplasia (GENEM)].
Calender A; Giraud S; Porchet N; Gaudray P; Cadiot G; Mignon M
Ann Endocrinol (Paris); 1998; 59(6):444-51. PubMed ID: 10189986
[TBL] [Abstract][Full Text] [Related]
42. MEN I gene mutations in sporadic adrenal adenomas.
Schulte KM; Heinze M; Mengel M; Simon D; Scheuring S; Köhrer K; Röher HD
Hum Genet; 1999 Dec; 105(6):603-10. PubMed ID: 10647896
[TBL] [Abstract][Full Text] [Related]
43. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
44. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
Uchino S; Noguchi S; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Ohshima A; Futata T; Mizukoshi T; Koike E; Takatsu K; Terao K; Wakiya S; Nagatomo M; Adachi M
Cancer Res; 2000 Oct; 60(19):5553-7. PubMed ID: 11034102
[TBL] [Abstract][Full Text] [Related]
45. The MEN-1 gene is rarely down-regulated in pituitary adenomas.
Asa SL; Somers K; Ezzat S
J Clin Endocrinol Metab; 1998 Sep; 83(9):3210-2. PubMed ID: 9745428
[TBL] [Abstract][Full Text] [Related]
46. Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancer.
Schulte KM; Mengel M; Heinze M; Simon D; Scheuring S; Köhrer K; Röher HD
J Clin Endocrinol Metab; 2000 Jan; 85(1):441-8. PubMed ID: 10634422
[TBL] [Abstract][Full Text] [Related]
47. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas.
Hessman O; Lindberg D; Skogseid B; Carling T; Hellman P; Rastad J; Akerström G; Westin G
Cancer Res; 1998 Feb; 58(3):377-9. PubMed ID: 9458074
[TBL] [Abstract][Full Text] [Related]
48. Biallelic inactivation by somatic mutations of the MEN1 gene in sporadic parathyroid tumors.
Tanaka C; Uchino S; Noguchi S; Nishioka T; Yamasaki H; Hashimoto K; Yoshimoto K
Cancer Lett; 2002 Jan; 175(2):175-9. PubMed ID: 11741745
[TBL] [Abstract][Full Text] [Related]
49. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
50. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families.
Sato M; Matsubara S; Miyauchi A; Ohye H; Imachi H; Murao K; Takahara J
J Med Genet; 1998 Nov; 35(11):915-9. PubMed ID: 9832038
[TBL] [Abstract][Full Text] [Related]
51. Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions.
Cavaco BM; Domingues R; Bacelar MC; Cardoso H; Barros L; Gomes L; Ruas MM; Agapito A; Garrão A; Pannett AA; Silva JL; Sobrinho LG; Thakker RV; Leite V
Clin Endocrinol (Oxf); 2002 Apr; 56(4):465-73. PubMed ID: 11966739
[TBL] [Abstract][Full Text] [Related]
52. Screening for MEN1 mutations in patients with atypical endocrine neoplasia.
Dackiw AP; Cote GJ; Fleming JB; Schultz PN; Stanford P; Vassilopoulou-Sellin R; Evans DB; Gagel RF; Lee JE
Surgery; 1999 Dec; 126(6):1097-103; discussion 1103-4. PubMed ID: 10598193
[TBL] [Abstract][Full Text] [Related]
53. Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma.
Böni R; Vortmeyer AO; Huang S; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1999 Jun; 9(3):249-52. PubMed ID: 10465580
[TBL] [Abstract][Full Text] [Related]
54. Thymic carcinoids in multiple endocrine neoplasia type 1.
Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Ann Surg; 1998 Jul; 228(1):99-105. PubMed ID: 9671073
[TBL] [Abstract][Full Text] [Related]
55. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma.
Debelenko LV; Swalwell JI; Kelley MJ; Brambilla E; Manickam P; Baibakov G; Agarwal SK; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Travis WD; Emmert-Buck MR
Genes Chromosomes Cancer; 2000 May; 28(1):58-65. PubMed ID: 10738303
[TBL] [Abstract][Full Text] [Related]
56. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis.
Poncin J; Stevenaert A; Beckers A
Eur J Endocrinol; 1999 Jun; 140(6):573-6. PubMed ID: 10366412
[TBL] [Abstract][Full Text] [Related]
57. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
[TBL] [Abstract][Full Text] [Related]
58. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
Tahara H; Imanishi Y; Yamada T; Tsujimoto Y; Tabata T; Inoue T; Inaba M; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4113-7. PubMed ID: 11095441
[TBL] [Abstract][Full Text] [Related]
59. Role of the MEN1 tumour suppressor gene in human ductal pancreatic cancer.
Karges W; Maier S; Schmidt F; Gress TM; Boehm BO
Cancer Lett; 2000 Aug; 157(1):51-5. PubMed ID: 10893442
[TBL] [Abstract][Full Text] [Related]
60. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
